Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Living Donor Liver Transplantation Outcomes for Hepatocellular Carcinoma Beyond Milan or UCSF Criteria.

Gunay Y, Guler N, Yaprak O, Dayangac M, Akyildiz M, Altaca G, Yuzer Y, Tokat Y.

Indian J Surg. 2015 Dec;77(Suppl 3):950-6. doi: 10.1007/s12262-014-1078-6. Epub 2014 Apr 24.

PMID:
27011489
2.

Current developments in pediatric liver transplantation.

Hackl C, Schlitt HJ, Melter M, Knoppke B, Loss M.

World J Hepatol. 2015 Jun 18;7(11):1509-20. doi: 10.4254/wjh.v7.i11.1509. Review.

3.

2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma.

Korean Liver Cancer Study Group (KLCSG); National Cancer Center, Korea (NCC).

Korean J Radiol. 2015 May-Jun;16(3):465-522. doi: 10.3348/kjr.2015.16.3.465. Epub 2015 May 13.

4.

A new therapeutic assessment score for advanced hepatocellular carcinoma patients receiving hepatic arterial infusion chemotherapy.

Saeki I, Yamasaki T, Tanabe N, Iwamoto T, Matsumoto T, Urata Y, Hidaka I, Ishikawa T, Takami T, Yamamoto N, Uchida K, Terai S, Sakaida I.

PLoS One. 2015 May 20;10(5):e0126649. doi: 10.1371/journal.pone.0126649. eCollection 2015.

5.

2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Korean Liver Cancer Study Group (KLCSG); National Cancer Center, Korea (NCC).

Gut Liver. 2015 May 23;9(3):267-317. doi: 10.5009/gnl14460.

6.

Current management of hepatocellular carcinoma: an Eastern perspective.

Yim HJ, Suh SJ, Um SH.

World J Gastroenterol. 2015 Apr 7;21(13):3826-42. doi: 10.3748/wjg.v21.i13.3826. Review.

7.

Role of liver transplantation for hepatocellular carcinoma.

Kumaran V.

J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S97-S103. doi: 10.1016/j.jceh.2014.01.002. Epub 2014 Jan 23. Review.

8.

Role of surveillance in prevention of hepatocellular carcinoma.

Panda D.

J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S43-9. doi: 10.1016/j.jceh.2014.03.044. Epub 2014 May 25. Review.

9.

The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations.

Kumar A, Acharya SK, Singh SP, Saraswat VA, Arora A, Duseja A, Goenka MK, Jain D, Kar P, Kumar M, Kumaran V, Mohandas KM, Panda D, Paul SB, Ramachandran J, Ramesh H, Rao PN, Shah SR, Sharma H, Thandassery RB; (The INASL Task-Force on Hepatocellular Carcinoma).

J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S3-S26. doi: 10.1016/j.jceh.2014.04.003. Epub 2014 May 22. Review.

10.

Current and future challenges in the surgical treatment of hepatocellular carcinoma: a review.

Tsoulfas G, Agorastou P, Tooulias A, Marakis GN.

Int Surg. 2014 Nov-Dec;99(6):779-86. doi: 10.9738/INTSURG-D-13-00122.1. Review.

11.

Current management of hepatocellular carcinoma.

Tabrizian P, Roayaie S, Schwartz ME.

World J Gastroenterol. 2014 Aug 14;20(30):10223-37. doi: 10.3748/wjg.v20.i30.10223. Review.

12.

Living donor liver transplantation for patients with hepatocellular carcinoma.

Akamatsu N, Sugawara Y, Kokudo N.

Liver Cancer. 2014 May;3(2):108-18. doi: 10.1159/000343866. Review.

13.

Liver transplantation for malignancy: current treatment strategies and future perspectives.

Hackl C, Schlitt HJ, Kirchner GI, Knoppke B, Loss M.

World J Gastroenterol. 2014 May 14;20(18):5331-44. doi: 10.3748/wjg.v20.i18.5331. Review.

14.

Neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: where do we stand?

Fujiki M, Aucejo F, Choi M, Kim R.

World J Gastroenterol. 2014 May 14;20(18):5308-19. doi: 10.3748/wjg.v20.i18.5308.

15.

Time to transplantation as a predictor of hepatocellular carcinoma recurrence after liver transplantation.

Samoylova ML, Dodge JL, Yao FY, Roberts JP.

Liver Transpl. 2014 Aug;20(8):937-44. doi: 10.1002/lt.23902. Epub 2014 Jul 3.

16.

The stratifying value of Hangzhou criteria in liver transplantation for hepatocellular carcinoma.

Chen J, Xu X, Wu J, Ling Q, Wang K, Wang W, Zhang M, Shen Y, Zhou L, Xie H, Zheng S.

PLoS One. 2014 Mar 27;9(3):e93128. doi: 10.1371/journal.pone.0093128. eCollection 2014.

17.

Serum levels of preoperative α-fetoprotein and CA19-9 predict survival of hepatic carcinoma patients after liver transplantation.

Wan P, Zhang J, Long X, Li Q, Xu N, Zhang M, Chen X, Han L, Xia Q.

Eur J Gastroenterol Hepatol. 2014 May;26(5):553-61. doi: 10.1097/MEG.0000000000000070.

18.

Staging of biliary tract and primary liver tumors.

Shindoh J, Vauthey JN.

Surg Oncol Clin N Am. 2014 Apr;23(2):313-22. doi: 10.1016/j.soc.2013.11.003.

19.

Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation.

Xiao GQ, Liu C, Liu DL, Yang JY, Yan LN.

World J Gastroenterol. 2013 Dec 7;19(45):8398-407. doi: 10.3748/wjg.v19.i45.8398.

20.

Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma.

Kaseb AO, Shindoh J, Patt YZ, Roses RE, Zimmitti G, Lozano RD, Hassan MM, Hassabo HM, Curley SA, Aloia TA, Abbruzzese JL, Vauthey JN.

Cancer. 2013 Sep 15;119(18):3334-42. doi: 10.1002/cncr.28209. Epub 2013 Jul 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk